Company / Current Assets
Edesa Biotech, Inc. Current Assets History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$12.1M
FY2021
5-year range
$6.8M / $12.1M
FY2017-FY2021
Trend
+49.2%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 7 years, ranging from $7M in FY2017 to $14M in FY2015.
Based on SEC 10-K filings.
$12M in FY2021 with a 5-year CAGR of -0.0%.
Improved from $11M to $12M over the past 3 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +4.3%
- 5-Year CAGR
- -0.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.0%, indicating a declining trend.
- In FY2021, current assets increased 49.2% year-over-year.
- Peak current assets was recorded in FY2015.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $12.1M | +49.2% |
| FY2020 | $8.1M | -23.9% |
| FY2018 | $10.7M | +57.7% |
| FY2017 | $6.8M | -44.1% |
| FY2016 | $12.1M | -14.0% |
| FY2015 | $14.1M | +0.0% |
| FY2014 | $14.1M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026